Skip to main content

Moolec Science SA

For the period ended Nov 2, 2026. Filed Nov 2, 2026.

View on SEC.gov

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Nov 2, 2026 · Filed Nov 2, 2026

Use the contents to explore the available documents and sections.

MLEC$0.85-39.3%Stored close · as of Nov 2, 2026
See the whole filing, with its images and exhibits
Contents

Cover page

Show cover page

6-K 1 resign3.txt RESIGNATIONS CEO AND CFO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2026 Commission File Number: 001-41586 MOOLEC SCIENCE SA (Exact name of Registrant as Specified in Its Charter) 89 Nexus Way, Camana Bay Grand Cayman KY1-9009 Cayman Islands (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports* under cover of Form 20-F or Form 40-F. Form 20-F [X] Form 40-F [ ] EXPLANATORY NOTE Resignation of Chief Executive Officer and Chief Financial Officer On October 20, 2026, the shareholders of Moolec Science SA in Voluntary* Liquidation (the Company), at an Extraordinary General Meeting, approved the* voluntary winding-up of the Company and the appointment of Joint Voluntary* Liquidators, with 98.4 percent of the votes cast in favor of the resolutions. In connection with the Company's voluntary liquidation and the appointment of* the Joint Voluntary Liquidators, Mr. Alejandro Antalich resigned as Chief* Executive Officer and Ms. Valeria Falottico resigned as Chief Financial Officer* of the Company, with both resignations becoming effective immediately following* the filing of this Form 6-K. Following the appointment of the Joint Voluntary Liquidators, the management* and affairs of the Company transferred to the Joint Voluntary Liquidators, and* the executive powers of the Company's officers were effectively displaced. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the* registrant has duly caused this report to be signed on its behalf by the* undersigned, thereunto duly authorized. Moolec Science SA (registrant) Date: November 2, 2026 By: /s/ Alejandro Antalich Name: Alejandro Antalich Title: CEO

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.